Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01334983 · ClinicalTrials.gov registry record · Phase 2
Rapid Easy Strength Training (REST) to Improve Function in Late Stage Cancer
A Phase 2 study, sponsored by Mayo Clinic.
- Completed
- Registry status
- Phase 2
- Development phase
- 68
- Enrollment target
NCT01334983: Completed Phase 2 study, sponsored by Mayo Clinic.
NCT01334983 is a Phase 2 study that has completed, run by Mayo Clinic. The registered enrollment target is 68 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01334983, a Phase 2 study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 68 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether a gentle physical conditioning program comprised of isotonic resistive strengthening and pedometer-directed walking can improve the physical functioning and fatigue of patients with late stage lung or colon cancer.
Interventions
- BEHAVIORAL REST
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 68 participants |
| Start Date | 2010-06 |
| Est. Completion | 2010-11 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01334983
The ClinicalTrials.gov registry entry for NCT01334983 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 68 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which REST is the first listed.
NCT01334983 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01334983 about?
NCT01334983 is a clinical study titled "Rapid Easy Strength Training (REST) to Improve Function in Late Stage Cancer". The purpose of this study is to determine whether a gentle physical conditioning program comprised of isotonic resistive strengthening and pedometer-directed walking can improve the physical functioning and fatigue of patients with late stage lung or colon cancer.
What is the current status of trial NCT01334983?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 68 participants. The study started on 2010-06. Estimated completion is 2010-11.
What interventions are being tested in trial NCT01334983?
The interventions under investigation include: REST (BEHAVIORAL).
Who is sponsoring clinical trial NCT01334983?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.